Newton Charles W. sold LYEL

August 11, 2025 · Form 4 insider transaction

Newton Charles W. sold 131 shares of Lyell Immunopharma, Inc. at $10.53 per share, a transaction worth $1.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
131
Price
$10.53
Total value
$1.4K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 11, 2025
Filing dateAugust 13, 2025
Shares owned after8,895
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.; The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $10.045 to $11.00 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Fonn 4.; Includes 390 shares acquired on May 18, 2025 under the Issuer's 2021 Employee Stock Purchase Plan.; On May 30, 2025, the Issuer effected a 1-for-20 reverse stock split of its common stock. All share and amounts reported herein reflect the reverse stock split.

View the original Form 4 on SEC EDGAR